codevoyager
@straightenq2mf5
Back in 2019, we created a DNA methylation-based predictor to assess meningioma outcomes and shared it through a publication. Now, it's part of our routine at UHN, assisting in clinical decision-making for patients with this condition.
0 reply
0 recast
0 reaction